Literature DB >> 16950078

Predictors of discharge to an inpatient extended care facility after total hip or knee arthroplasty.

Kevin J Bozic1, Amy Wagie, James M Naessens, Daniel J Berry, Harry E Rubash.   

Abstract

Increased emphasis has been placed on hospital length of stay and discharge planning after total joint arthroplasty (TJA). The purpose of this study was to identify baseline patient characteristics that are predictive of discharge to an inpatient extended care facility (ECF) after TJA. Clinical, demographic, and resource utilization data were analyzed for 7818 consecutive patients who underwent primary or revision TJA at 1 of 3 high-volume TJA centers. A stepwise linear regression model was used to identify predictors of discharge to an ECF. Overall, 29% of patients were discharged to an ECF after TJA. Older age, higher American Society of Anesthesiologists class, Medicare insurance, and female sex were all associated with a higher likelihood of discharge to an ECF. Significant differences in practice patterns were found across hospitals with respect to discharge disposition after TJA. Further study is necessary to determine the appropriate criteria for discharge to an ECF after TJA.

Entities:  

Mesh:

Year:  2006        PMID: 16950078     DOI: 10.1016/j.arth.2006.04.015

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  37 in total

1.  Patient vs provider characteristics impacting hospital lengths of stay after total knee or hip arthroplasty.

Authors:  Joseph F Styron; Siran M Koroukian; Alison K Klika; Wael K Barsoum
Journal:  J Arthroplasty       Date:  2011-01-28       Impact factor: 4.757

2.  Predictors of Facility Discharge, Range of Motion, and Patient-Reported Physical Function Improvement After Primary Total Knee Arthroplasty: A Prospective Cohort Analysis.

Authors:  Cody M Rissman; Benjamin J Keeney; Ellyn M Ercolano; Karl M Koenig
Journal:  J Arthroplasty       Date:  2015-09-09       Impact factor: 4.757

3.  Blood management may have an impact on length of stay after total hip arthroplasty.

Authors:  Jad Bou Monsef; Friedrich Boettner
Journal:  HSS J       Date:  2014-04-08

4.  Does the Risk Assessment and Prediction Tool predict discharge disposition after joint replacement?

Authors:  Viktor J Hansen; Kirill Gromov; Lauren M Lebrun; Harry E Rubash; Henrik Malchau; Andrew A Freiberg
Journal:  Clin Orthop Relat Res       Date:  2015-02       Impact factor: 4.176

Review 5.  Enhanced recovery protocols in total joint arthroplasty: a review of the literature and their implementation.

Authors:  A S Galbraith; E McGloughlin; J Cashman
Journal:  Ir J Med Sci       Date:  2017-06-16       Impact factor: 1.568

6.  Comparison of outcome measures from different pathways following total knee arthroplasty.

Authors:  Hiok Yang Chan; Rehena Sultana; Seng Jin Yeo; Shi-Lu Chia; Hee Nee Pang; Ngai Nung Lo
Journal:  Singapore Med J       Date:  2018-01-26       Impact factor: 1.858

7.  Benign heart murmurs as a predictor for complications following total joint arthroplasty.

Authors:  James M Friedman; Ricardo Couso; Michael Kitchens; Venus Vakhshori; Cody D Hillin; Chia H Wu; Joshua Steere; Jaimo Ahn; Eric Hume
Journal:  J Orthop       Date:  2017-08-01

8.  Hospital volume and surgical outcomes after elective hip/knee arthroplasty: a risk-adjusted analysis of a large regional database.

Authors:  Jasvinder A Singh; C Kent Kwoh; Robert M Boudreau; Gwo-Chin Lee; Said A Ibrahim
Journal:  Arthritis Rheum       Date:  2011-08

9.  Sex and surgical outcomes and mortality after primary total knee arthroplasty: a risk-adjusted analysis.

Authors:  Jasvinder A Singh; C Kent Kwoh; Diane Richardson; Wei Chen; Said A Ibrahim
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-07       Impact factor: 4.794

10.  A nationwide analysis of risk factors for in-hospital myocardial infarction after total joint arthroplasty.

Authors:  Mariano E Menendez; Stavros G Memtsoudis; Marion Opperer; Friedrich Boettner; Alejandro Gonzalez Della Valle
Journal:  Int Orthop       Date:  2014-08-30       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.